ArticleScientific reports2025
Positive lymph node ratio as a nodal staging system to avoid stage migration between remnant and primary proximal gastric cancers.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of lymph node ratio after neoadjuvant chemotherapy for gastric cancer: a systematic review and meta-analysis.Frontiers in oncology · 2026Pooled it
- Prognostic impact of lymph node ratio after suboptimal lymphadenectomy in gastric cancer: a retrospective cohort study with interaction analysis.World journal of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nodal staging of gastric cancer (GC) based on the number of positive lymph nodes (PLNs) is a robust prognostic factor. However, the number of retrieved lymph nodes in remnant GC (RGC) may be lower than in primary GC owing to variations in the extents of initial gastrectomy and lymphadenectomy. This study evaluated stage migration between RGC and primary proximal gastric cancer (PGC) and the clinical usefulness of the PLN ratio (PLNR) in mitigating stage migration. Among 4,142 patients who underwent gastrectomy, 91 with RGC and 768 with PGC at pStage I-III were retrospectively analyzed. A PLNR of 0.3 was the best-stratified prognosis (p < 0.001). Five-year survival in pN1-3 RGC was worse than in PGC, whereas pN0 showed no prognostic difference. PLNR stratification (0, < 0.3, and ≥ 0.3) effectively distinguished prognosis in patients with RGC (82.2, 46.6, 12.7%, respectively) and PGC (88.9, 63.4, 16.4%, respectively). High PLNR (≥ 0.3) was an independent prognostic factor in RGC (HR: 2.76, 95% CI: 1.06-7.17, p = 0.036), whereas pN stage was not. Prognostic stratification was reliable with at least five dissected lymph nodes. PLNR provides effective prognostic stratification in RGC and helps evaluate stage migration between RGC and primary PGC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.